Related references
Note: Only part of the references are listed.Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations
Mustapha Amyere et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1)
Claire A. Hudson et al.
MOLECULAR HUMAN REPRODUCTION (2012)
Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
David A. McDonald et al.
STROKE (2012)
The myosin phosphatase targeting protein (MYPT) family: A regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ
Michael E. Grassie et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease
David A. McDonald et al.
HUMAN MOLECULAR GENETICS (2011)
Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype
Asya L. Borikova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
Rebecca A. Stockton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
Axel Pagenstecher et al.
HUMAN MOLECULAR GENETICS (2009)
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
Amy L. Akers et al.
HUMAN MOLECULAR GENETICS (2009)
Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells
Lisa E. S. Crose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
Kevin J. Whitehead et al.
NATURE MEDICINE (2009)
CEREBRAL CAVERNOUS MALFORMATIONS: SOMATIC MUTATIONS IN VASCULAR ENDOTHELIAL CELLS
Judith Gault et al.
NEUROSURGERY (2009)
The putative role of the venous system in the genesis of vascular malformations
Mariam S. Aboian et al.
NEUROSURGICAL FOCUS (2009)
Quality scores and SNP detection in sequencing-by-synthesis systems
William Brockman et al.
GENOME RESEARCH (2008)
EXTREME DE NOVO APPEARANCE OF CEREBRAL CAVERNOUS MALFORMATIONS
Patrick J. Reid et al.
NEUROSURGERY (2008)
Genotype-phenotype correlations in cerebral cavernous malformations patients
Christian Denier et al.
ANNALS OF NEUROLOGY (2006)
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis
JS Zawistowski et al.
HUMAN MOLECULAR GENETICS (2005)
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
J Gault et al.
STROKE (2005)
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations
F Bergametti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Mutations within the MGC4607 gene cause cerebral cavernous malformations
C Denier et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations
CL Liquori et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Factors affecting PCR-mediated recombination
S Shafikhani
ENVIRONMENTAL MICROBIOLOGY (2002)
Share Paper
